Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab

1. Motzer, R.
2. George, S.
3. Merchan, J.R.
4. Hutson, T.E.
5. Song, X.
6. Perini, R.F.
7. Xie, R.
8. Bapat, U.
9. Puente, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ONCOLO/OYAC269 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus